1089 participants
A Clinical Study of Intismeran Autogene (V940) Plus Pembrolizumab in People With High-Risk Melanoma (V940-001)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2025-09-24
- Start Date:
- 2023-07-19
- Completion:
- 2029-10-26
Conditions
- Melanoma
Interventions
- BIOLOGICAL
- OTHER
No Results Yet